Outset Medical, Inc.(OM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bank Of Montreal ("BoM" or "the Company") (NYSE: BMO). Investors who purchased BoM securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/BMO.
Investigation Details
On August 27, 2024, BoM reported its financial results for the third quarter of 2024. Among other items, BoM reported adjusted earnings per share of C$2.64 (US$1.96), missing consensus estimates for the third consecutive quarter. The Company also increased its provision for credits loses to C$906 million, compared to C$492 million for the same period in the prior year. In response, Jefferies downgraded BoM's stock to Hold from Buy. On this news, BoM's stock price fell $5.47 per share, or 6.16%, to close at $83.30 per share on August 27, 2024.
What's Next?
If you are aware of any facts relating to this investigation or purchased BoM securities, you can assist this investigation by visiting the firm's site: bgandg.com/BMO. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com
View original content to download multimedia: https://www.prnewswire.com/news-releases/outset-medical-incom-investigation-bronstein-gewirtz--grossman-llc-encourages-investors-to-contact-the-firm-to-learn-more-about-the-investigation-302235415.html
SOURCE Bronstein, Gewirtz & Grossman, LLC
